Jay Jackson

Vice President HEOR Vera Therapeutics

Jay Jackson, PharmD, MPH, BCMAS is a Vice President, Health Economics and Outcomes Research (HEOR) at Vera Therapeutics. Jay is an experienced professional within the biopharmaceutical, medical device, and digital therapeutics industry where he has partnered with US and global clients for 25 years to provide value driven solutions that demonstrate brand value and maximize patient access to therapies. Jay has passion and demonstrates the ability to develop meaningful HEOR evidence to deliver value across the product life cycle for successful commercialization of novel therapies. Prior to joining Vera, Jay was a Partner at Herspiegel where he built and led the Market Access Practice. Prior to Herspiegel, he led a team at Xcenda of approximately 300 scientific research and commercial market access consultants across the US, Canada, UK, Germany, Spain, and Switzerland. Jay was instrumental in the strategic guidance of evidence generation tactics and the development of numerous interactive customer tools and market access strategies. He partnered with numerous manufacturers to support brand planning and tactical execution that included the design, development, and implementation of well over 300 HEOR studies. Dr. Jackson's experience ranges across multiple therapeutic areas, including nephrology, oncology, cardiovascular, respiratory, autoimmune, infectious disease, central nervous system disorders, and rare diseases. Dr. Jackson has been an invited speaker at national conferences and has authored numerous peer-reviewed articles. Dr. Jackson received his Doctor of Pharmacy degree from the Mercer University Southern School of Pharmacy in 1999. His postdoctoral training includes the completion of an Outcomes Research Fellowship at Mercer University Southern School of Pharmacy and Xcenda/Cencora. He received a Master of Public Health in Epidemiology from the University of South Florida College of Public Health. Dr. Jackson also has a Board Certification in Medical Affairs.